6 Healthcare Quality Analytics Platforms Every Health Care Quality Manager Should Know in 2026

MacBook Pro near white open book and coffeeWritten by Cass Rosas,

Quality managers carry an odd burden. They’re expected to prove improvement to regulators and payers, yet the data behind that proof usually sits in a dozen disconnected systems. Charts still get abstracted by hand, and a single patient encounter can count toward several programs at once.

The workload is larger than most people outside the quality department assume. When researchers at Johns Hopkins catalogued one hospital’s reporting obligations, they identified 162 unique quality metrics and estimated that preparing and reporting the data took 108,478 person-hours in a single year. Personnel costs came to more than $5 million, plus roughly $600,000 in vendor fees (Saraswathula et al., 2023).

Quality analytics platforms are meant to cut that workload and give teams time back for improvement work. Each of the six below solves a different problem, so read this list as a matching guide. The right choice depends on where your organization’s biggest gap sits: regulatory reporting, provider performance, patient experience, population health, or safety.

What Healthcare Quality Analytics Platforms Actually Do

A quality analytics platform pulls clinical, claims, survey, and event data into one place and calculates performance against defined measures. The platform ships with the measure specifications, including numerator and denominator logic, and updates them when CMS or NCQA revises a measure. With a general BI tool such as Tableau, someone on staff has to build and maintain that logic by hand. Many also submit results directly to CMS.

Quality management software in the narrower sense does a different job. Incident reporting and corrective and preventive action (CAPA) tools document what happened and how the organization responded. Analytics tools measure performance over time. Most quality departments need both, and a few vendors sell both.

These platforms touch nearly every recurring obligation a quality manager has. That list includes electronic clinical quality measures (eCQMs) for the Hospital Inpatient Quality Reporting (IQR) Program, MIPS for clinicians, HEDIS and Medicare Star Ratings for health plans and their provider partners, and HCAHPS for patient experience. Patient safety indicators feed directly into accreditation readiness for The Joint Commission.

How We Chose These 6 Platforms

We judged each platform on five criteria:

  • Data sources supported, including EHR, claims, patient surveys, and incident reports
  • Measure libraries, meaning prebuilt and maintained measure logic for CMS and NCQA programs
  • Regulatory submission support where it applies
  • Benchmarking against national or peer data
  • Usability for quality staff who aren’t trained data analysts

We also picked each one to cover a distinct use case. A hospital working through eCQM submission and a self-insured employer trying to steer members toward stronger physicians both need quality analytics. They need very different tools to get it.

6 Healthcare Quality Analytics Platforms to Know in 2026

1. Garner Health: Provider Quality and Outcomes Data

Garner Health measures performance for individual physicians.

Garner reports that it has compiled more than 60 billion medical records from 320 million patients and uses them to identify which doctors diagnose more accurately and achieve better patient outcomes (Garner Health, n.d.). The data is claims-based, so it shows what happened to patients in the months after a visit as well as whether a process step was documented.

That matters most in referral and network decisions. Two orthopedic surgeons in the same network can have very different complication and revision rates, and a standard facility dashboard won’t separate them. Outcome-based provider data gives quality and care management teams an objective basis for steering patients and for value-based care discussions with employers and health plans.

Garner’s primary customers are self-funded employers and the brokers who advise them, with employees as the end users. Hospital quality departments are more likely to run into it through payer and employer partnerships than as an internal reporting system, though Garner does license its provider data directly to health systems and carriers

2. Medisolv: eCQM and CMS Quality Reporting

Medisolv sticks to the regulatory side of quality. Its software calculates and validates eCQMs from EHR data and supports submissions for Hospital IQR and MIPS, among other CMS programs.

The practical appeal is early warning. Quality teams can watch measure performance through the year and fix documentation gaps months before a submission deadline. Medisolv fits hospitals and physician groups whose main pain point is CMS reporting. Organizations looking for a broad enterprise data platform will probably find it too narrow.

3. Health Catalyst: Enterprise Clinical Quality Improvement

Health Catalyst covers far more ground. It pairs a healthcare data platform with analytics applications and improvement services for health systems running many improvement projects at once.

Its strength is breadth. A health system can bring clinical and financial data together and track a sepsis bundle project alongside a readmissions effort in the same environment. That breadth comes with a real implementation commitment, including data engineering staff and executive sponsorship. Smaller hospitals often can’t justify it.

4. Press Ganey: Patient Experience and Safety Analytics

Patient experience has direct financial consequences, since HCAHPS results feed into CMS Hospital Value-Based Purchasing. Press Ganey is best known for patient experience surveys and for benchmarking results against a large national comparison database.

It’s most useful when quality managers read experience data next to clinical and safety data. A unit with falling nurse communication scores and rising medication events probably has one underlying problem. Press Ganey also measures workforce engagement and safety culture, which helps when staffing sits underneath a quality issue.

5. Arcadia: Population Health and HEDIS Gap Closure

Arcadia serves organizations accountable for a defined population, such as ACOs and physician groups in value-based contracts. Its platform combines claims and clinical data to surface care gaps (overdue screenings, uncontrolled chronic conditions) and to track HEDIS and Star Ratings performance.

The difference from Medisolv is the unit of measurement. Medisolv tells a hospital whether it met its measures. Arcadia tells a care team which patients in its panel still need something done. For quality staff in ambulatory or payer settings, that patient-level work list is often the most useful output.

6. RLDatix: Patient Safety and Incident Analytics

Safety data needs its own tool. Reviewing a random sample of 2,809 admissions across 11 Massachusetts hospitals, Bates et al. (2023) found at least one adverse event in 23.6% of admissions and judged 22.7% of those events preventable.

RLDatix, which includes the long-established Datix incident reporting system, captures safety events and near misses and trends them by unit and severity. Those trends support root cause analysis and give surveyors the documentation they expect. RLDatix works best alongside the other tools on this list, because incident data catches harm that outcome and process measures can miss.

How to Match a Platform to Your Quality Program

The table below summarizes where each platform fits.

Platform Primary quality use case Best-fit setting Main data source
Garner Health Provider-level outcomes and referral quality Employers, health plans, care management Claims
Medisolv eCQM and CMS program reporting Hospitals, physician groups EHR
Health Catalyst Enterprise improvement across service lines Large health systems EHR, financial, operational
Press Ganey Patient experience and safety culture Hospitals, health systems Patient and staff surveys
Arcadia Care gaps, HEDIS, value-based contracts ACOs, payers, ambulatory groups Claims and EHR
RLDatix Incident reporting and safety trending Hospitals, long-term care Incident and event reports

 

Start with the problem that eats the most staff time or carries the most financial risk. Before booking demos, check whether the tool connects cleanly with your EHR and whether its measure library covers the programs you actually report to. Then be honest about whether your team can maintain it after go-live.

Questions to Ask During a Vendor Demo

  • How do you validate measure logic each year when CMS or NCQA updates specifications?
  • How often does data refresh, and how long is the lag between a patient encounter and its appearance in a dashboard?
  • Where do benchmarks come from, and how large is the comparison group?
  • Can quality staff build or adjust reports without submitting a request to IT?
  • What analyst or clinical support does the contract include, and what costs extra?
  • Can we speak with a current customer of similar size and setting?

Building Data Skills on Your Quality Team

Software doesn’t interpret itself. Every platform on this list depends on staff who can read a measure specification and catch an exclusion applied incorrectly. They also need to tell a real performance change from a documentation artifact. Teams without those skills tend to produce attractive dashboards that nobody trusts.

So the investment has to cover people as well as technology. Quality professionals who understand measurement science and the regulatory programs behind the numbers get far more out of any platform they adopt. AIHCP’s Health Care Quality Management Certification is one route for nurses and allied health professionals who want formal training in those competencies.

Frequently Asked Questions

What Is a Healthcare Quality Analytics Platform?

A healthcare quality analytics platform is software that collects clinical, claims, survey, or event data and calculates performance on defined quality measures. Most include prebuilt measure logic and benchmarking against peer or national data, with dashboards that show where performance falls short. Some also submit results to CMS or other reporting bodies. The point is to move staff time from gathering data to improving care.

Is Quality Analytics the Same as Quality Management Software?

No. Quality analytics measures performance on outcome and process measures over time. Quality management software documents events and the organization’s response to them, through tools such as incident reporting and CAPA tracking. Many quality departments use both, and some vendors, including RLDatix, sell products in each category.

What Data Sources Do Quality Analytics Platforms Use?

Quality analytics platforms typically draw on EHR data, administrative claims, patient experience surveys, and incident reports. The source determines what the tool can measure. EHR data supports eCQMs and process measures, while claims data supports outcomes and utilization across care settings. Surveys add the patient’s perspective. Platforms that combine several sources give the fullest picture but take more integration work.

Do Small Practices Need a Dedicated Quality Analytics Tool?

Not always. Small practices with limited reporting obligations can often meet MIPS requirements through their EHR’s built-in reporting or a qualified registry. A dedicated platform starts to make sense once a practice joins value-based contracts or needs patient-level care gap lists to manage a defined population. Reporting volume and financial risk should drive the decision.

 

Author bio:

Cass Rosas is a content writer who covers healthcare technology, data, and analytics. She researches how health systems, payers, and employers use software to measure and improve care quality, and writes guides that help healthcare professionals compare tools.

 

Please also review AIHCP’s Health Care Quality Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Personalized Healthcare: Why One-Size-Fits-All Treatment Approaches May Fall Short

Cartoon laptop with medical symbols from varying fields of medicine on it.

Written by Amanda Collins,

For most of modern medical history, treatment has been built around the average patient. Clinical trials enroll a defined population, researchers measure how that population responds to a drug or intervention, and the results become the basis for guidelines that are then applied broadly. This approach has produced enormous public health gains, but it has an inherent limitation: no single patient is actually “average.” As healthcare professionals increasingly recognize, the gap between population-level evidence and individual patient response is where a great deal of ineffective, and sometimes harmful, care originates. Personalized, or precision, medicine is the growing effort to close that gap.

The Problem with Standardized Treatment

Clinical guidelines are, by design, statistical summaries. A dosing recommendation or first-line therapy is typically the option that performed best on average across a trial population. But “best on average” can obscure enormous variation underneath. A medication that produces strong benefit in the majority of trial participants may be ineffective, or even harmful, in a meaningful minority. Genetics, metabolism, body composition, comorbid conditions, and lifestyle factors all influence how an individual actually responds to a given intervention, yet standardized protocols often cannot account for all of these variables at the point of care.

Guidelines still serve an essential purpose: they give clinicians a defensible, evidence-based starting point, and quality-of-care frameworks like those taught in health care quality management certification programs exist precisely to help systems balance consistency with outcomes. But a starting point is not a finish line, and treating it as one is where standardization tends to fail patients.

This is part of why interest in individualized health optimization has grown well beyond the prescription pad. Patients are increasingly proactive about supporting their own physiology based on their personal biomarkers and goals, whether that means requesting more detailed lab panels or exploring targeted nutritional support such as premium NMN supplements, which some patients pursue as part of a broader, individualized approach to cellular energy metabolism and healthy aging. The larger point clinicians should take from this trend is not about any one product category. It’s that patients themselves are already thinking about their care in more personalized terms than the standard treatment model typically offers.

The consequences of ignoring this variability are not trivial. In the case of pharmaceuticals, adverse drug reactions are estimated to be the fourth leading cause of death in the United States, contributing to roughly 128,000 deaths and $136 billion in costs annually, a burden larger than the total cost of cardiovascular or diabetes care.

A meaningful share of that burden traces back to treatment decisions made for the “average” patient rather than the one actually sitting in the exam room.

Why People Respond Differently

The biological basis for variable treatment response is well established. Pharmacogenomics, the study of how genetic variation affects drug metabolism, has shown that genetic factors alone can account for anywhere from 20% to 95% of the variability seen in drug response, depending on the medication and condition involved.

 Variants in genes encoding cytochrome P450 enzymes, for example, determine whether a patient metabolizes a given drug quickly, slowly, or not at all, directly affecting both efficacy and the risk of toxicity.

Genetics is only one piece of the puzzle. Body composition and age change how drugs distribute and clear from the body. Pre-existing conditions can alter organ function in ways that affect dosing safety margins. And a newer area of research, sometimes called pharmacomicrobiomics, has demonstrated that differences in gut microbiome composition can meaningfully influence drug absorption and metabolism, adding yet another layer of individual variability that standard protocols rarely capture.

Taken together, these factors explain why two patients with the same diagnosis, given the same medication at the same dose, can have entirely different outcomes.

Where This Shows Up in Practice

These effects are not theoretical: they show up across common areas of clinical care:

Antidepressant prescribing is a frequently cited example of trial-and-error medicine. In the landmark STAR*D trial, only about a third of patients achieved remission on their first antidepressant, with response rates dropping further at each subsequent treatment step.

Much of this variability is now understood to relate to genetic differences in how patients metabolize SSRIs and other psychiatric medications, which is why pharmacogenomic testing prior to prescribing is gaining traction in psychiatric practice.

Statin response varies considerably as well. Some patients achieve significant LDL reduction on a standard dose, while others see minimal benefit or experience side effects such as myopathy, often tied to genetic differences in drug transport and metabolism.

Cancer treatment has arguably moved furthest toward personalization. Tumor genomic profiling now routinely informs chemotherapy selection, allowing oncologists to match specific targeted therapies to the molecular characteristics of a patient’s tumor rather than relying solely on cancer type and stage. A related example is clopidogrel therapy in cardiovascular medicine, where genetic variation in the CYP2C19 gene means up to 30% of patients treated for acute coronary syndrome show a poor response to the standard regimen, with heritability accounting for the majority of that variability.<sup>6</sup>

Diabetes management protocols illustrate a different kind of mismatch, not pharmacogenomic, but behavioral. Standardized dietary and medication regimens frequently fail to account for a patient’s work schedule, food access, cultural food practices, or comorbid conditions, all of which affect whether a plan is actually sustainable.

What Personalized Care Looks Like Instead

Precision medicine does not mean discarding evidence-based guidelines; it means using them as a starting point rather than a final answer, then adjusting based on the individual in front of the clinician. In practice, this looks like several concrete shifts in care delivery:

  • Genetic testing before prescribing, particularly for drug classes with well-documented pharmacogenomic variability, such as certain antidepressants, antiplatelet agents, and chemotherapy drugs.
  • Biomarker-driven treatment planning, using more thorough bloodwork and diagnostic panels to guide decisions rather than defaulting to standard dosing based on age and weight alone.
  • Lifestyle-integrated care plans that account for a patient’s actual daily routine, occupation, and support system, rather than assuming a uniform capacity to follow a rigid protocol.
  • Clinician-led assessment over protocol-driven defaults, restoring the physician’s judgment as the final filter through which population-level guidelines are applied to a specific patient. This is also where case management plays an underappreciated role: professionals trained through programs like AIHCP’s case management certification are often the ones coordinating across specialists, translating biomarker-driven plans into something a patient can actually follow day to day.

This shift is also visible in the growth of specialized, condition-focused clinics that build their entire care model around individualized assessment rather than generic primary care visits. Men’s health has become a particularly active area for this kind of specialization, with dedicated practices offering in-depth hormone panels, metabolic testing, and tailored treatment plans that a standard 15-minute appointment often cannot accommodate. A patient in the Midwest, for instance, might seek out a men’s health clinic in St. Louis specifically because it offers more comprehensive, individualized diagnostic workups for concerns like low testosterone, fatigue, or metabolic changes than a general practice visit typically allows. This trend reflects a broader consumer expectation: patients want their care to be built around their specific physiology, not a generic template.

The Role of Technology

Much of what makes personalized care more feasible today than it was a decade ago comes down to technology. Direct-to-consumer and clinician-ordered genetic testing has become dramatically more affordable, making pharmacogenomic screening realistic for routine use rather than a specialty-only tool. Telehealth platforms have expanded access to specialists who can interpret complex biomarker data, particularly for patients outside major metropolitan areas. Wearable devices and continuous monitoring tools now generate real-time physiological data (glucose trends, heart rate variability, sleep architecture) that can inform treatment adjustments far more responsively than periodic office visits alone.

Electronic health records with integrated clinical decision support are also beginning to flag gene-drug interactions automatically, reducing the burden on clinicians to remember every relevant pharmacogenomic interaction. Collectively, these tools are lowering the cost and complexity of individualized assessment, moving precision medicine from a resource reserved for academic medical centers toward something achievable in routine practice.

Takeaway

Personalized medicine is not about adding complexity for its own sake, nor is it a rejection of the clinical trial evidence that underlies modern medical guidelines. It is about recognizing that guidelines describe an average patient who does not exist in any single exam room. The genetic makeup, metabolism, lifestyle, and health history of the actual person receiving care all shape how that care should be delivered. As genetic testing, biomarker panels, and digital health tools become more accessible, healthcare professionals have a growing set of tools to close the gap between population averages and individual outcomes, and an increasing responsibility to use them. The National Institutes of Health has framed this shift plainly: medicine has long relied on an expected “average” response, and precision medicine exists to correct for the patients that approach leaves behind. For healthcare professionals looking to build these principles into their own practice, resources like AIHCP’s continuing education and certification programs offer a practical next step toward more individualized, patient-centered care.

References

  1. Medical Laboratory Observer. (n.d.). The role of pharmacogenomics in precision medicine.
  2. PMC. (2024). The role of pharmacogenomics studies for precision medicine among Ethiopian patients and their clinical implications: A scoping review.
  3. IntechOpen. (2023). Pharmacogenomics – A prospective journey towards precision medicine.
  4. PMC. (2023). Drug-microbiota interactions: An emerging priority for precision medicine.
  5. Psychiatric Times / Carlat Publishing. (2024–2026). STAR*D reanalysis and antidepressant remission rate coverage.
  6. PMC. (2018). Pharmacogenomic impact of CYP2C19 variation on clopidogrel therapy in precision cardiovascular medicine.

 

About the Author

Amanda Collins is a healthcare writer and patient advocacy specialist with over a decade of experience covering clinical practice, care coordination, and health system design. Her work focuses on translating complex health policy and research into rigorous, evidence-informed content for clinical professionals. Amanda has contributed to a range of professional health publications and holds a particular interest in neurodevelopmental intervention, chronic disease management, and the structural determinants of healthcare quality.

 

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification